Cholecalciferol Supplementation Induced Up-Regulation of SARAF Gene and Down-Regulated miR-155-5p Expression in Slovenian Patients with Multiple Sclerosis

por Gselman, Saša, Fabjan, Tanja Hojs, Bizjak, Anja, Potočnik, Uroš, Gorenjak, Mario
Publicado 2023

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

por Berger, Thomas, Adamczyk-Sowa, Monika, Csépány, Tünde, Fazekas, Franz, Fabjan, Tanja Hojs, Horáková, Dana, Ledinek, Alenka Horvat, Illes, Zsolt, Kobelt, Gisela, Jazbec, Saša Šega, Klímová, Eleonóra, Leutmezer, Fritz, Rejdak, Konrad, Rozsa, Csilla, Sellner, Johann, Selmaj, Krzysztof, Štouracˇ, Pavel, Szilasiová, Jarmila, Turcˇáni, Peter, Vachová, Marta, Vanecková, Manuela, Vécsei, László, Havrdová, Eva Kubala
Publicado 2020

How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?

por Fazekas, Franz, Bajenaru, Ovidiu, Berger, Thomas, Fabjan, Tanja Hojs, Ledinek, Alenka Horvat, Jakab, Gábor, Komoly, Samuel, Kobys, Tetiana, Kraus, Jörg, Kurča, Egon, Kyriakides, Theodoros, Lisý, L'ubomír, Milanov, Ivan, Nehrych, Tetyana, Moskovko, Sergii, Panayiotou, Panayiotis, Jazbec, Saša Šega, Sokolova, Larysa, Taláb, Radomír, Traykov, Latchezar, Turčáni, Peter, Vass, Karl, Vella, Norbert, Voloshyná, Nataliya, Havrdová, Eva
Publicado 2013